Details for New Drug Application (NDA): 202114
✉ Email this page to a colleague
The generic ingredient in DONEPEZIL HYDROCHLORIDE is donepezil hydrochloride. There are thirty-two drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the donepezil hydrochloride profile page.
Summary for 202114
Tradename: | DONEPEZIL HYDROCHLORIDE |
Applicant: | Rising |
Ingredient: | donepezil hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 202114
Mechanism of Action | Cholinesterase Inhibitors |
Suppliers and Packaging for NDA: 202114
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DONEPEZIL HYDROCHLORIDE | donepezil hydrochloride | TABLET;ORAL | 202114 | ANDA | Graviti Pharmaceuticals Private Limited | 69844-037 | 69844-037-01 | 30 TABLET, FILM COATED in 1 BOTTLE (69844-037-01) |
DONEPEZIL HYDROCHLORIDE | donepezil hydrochloride | TABLET;ORAL | 202114 | ANDA | Graviti Pharmaceuticals Private Limited | 69844-037 | 69844-037-02 | 90 TABLET, FILM COATED in 1 BOTTLE (69844-037-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Jul 5, 2013 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Jul 5, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription